» Authors » Antonio Carlos Buzaid

Antonio Carlos Buzaid

Explore the profile of Antonio Carlos Buzaid including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 58
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Taranto P, de Brito Sales D, Maluf F, Guendelmann R, Pompei L, Leal A, et al.
Breast Cancer Res . 2024 Sep; 26(1):133. PMID: 39285489
Background: Premenopausal, high-risk, hormone receptor-positive breast cancer patients are often treated with ovarian suppression in combination with aromatase inhibitors (AI). This combination has important adverse effects, particularly in sexual function,...
2.
Barbosa C Rocha F, Falcone A, Buzaid A, Pimenta J, Schvartsman G, Frasson A
Breast Cancer Res Treat . 2018 Aug; 172(2):265-272. PMID: 30099633
Purpose: Breast cancer neoadjuvant chemotherapy (NAC) consists of the administration of cytotoxic and targeted drugs prior to breast surgery, with the objective of reducing the tumor burden to allow breast...
3.
da Rocha Lino A, Abrahao C, Brandao R, Ribeiro Gomes J, Ferrian A, Machado M, et al.
J Gastrointest Oncol . 2015 Oct; 6(5):511-5. PMID: 26487945
Background: Cancer of the exocrine pancreas is a highly lethal malignancy. Surgical resection is the only potentially curative treatment. Unfortunately, because of the late presentation, the majority have either locally...
4.
Ciria H, Morales Gonzalez M, Zamora L, Cabrales L, Gonzalez G, de Oliveira L, et al.
Chin J Cancer Res . 2013 Apr; 25(2):223-34. PMID: 23592904
Electrochemical treatment is an alternative modality for tumor treatment based on the application of a low intensity direct electric current to the tumor tissue through two or more platinum electrodes...
5.
Buzaid A, Schmerling R, Guedes R, de Freitas D, William Jr W
Melanoma Res . 2011 May; 21(4):370-5. PMID: 21558968
The objective of this study was to report our experience with 38 consecutive patients with metastatic melanoma treated with high-dose (HD) bolus interleukin (IL)-2 after disease progression on or after...
6.
Akaishi E, Teixeira F, Katayama M, Mizumoto N, Costa F, Buzaid A, et al.
World J Surg . 2009 Jan; 33(4):835-9. PMID: 19169741
Background: The objective of this study was to evaluate the long-term outcomes of a single institution, Hospital Sírio-Libanes in São Paulo, Brazil, regarding the treatment of peritoneal carcinomatosis. Methods: Between...
7.
Cazap E, Buzaid A, Garbino C, de la Garza J, Orlandi F, Schwartsmann G, et al.
Cancer . 2008 Oct; 113(8 Suppl):2359-65. PMID: 18837031
The incidence of breast cancer in Latin American countries is lower than that in more developed countries, whereas the mortality rate is higher. These differences probably are related to differences...
8.
Maluf F, Fernandes G, Kann A, Aguilar-Ponce J, de la Garza J, Buzaid A
Cancer Treat Rev . 2008 Sep; 34(8):750-60. PMID: 18801619
Renal cell carcinoma represents nearly 3% of all cancers, predominantly affecting individuals >or=50 years of age, and until recently, few treatments options were available for metastatic disease. The 5-year median...
9.
Riechelmann R, Hoff P, Moron R, da Camera Lopes L, Buzaid A
Int J Gastrointest Cancer . 2004 Sep; 34(2-3):67-72. PMID: 15361637
Acinar cell carcinoma of the pancreas is a rare tumor for which the best chemotherapy regimen has not been clearly established. Here, we report on a female patient with an...